Live Cell Imaging (LCI) Market Size, Share, Analysis Report

Live Cell Imaging (LCI) Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast

The global Live Cell Imaging (LCI) Market is expected to exceed US$ 11 Billion by 2028, with CAGR at 9% in the given forecast period.

Purchase User License

MARKET SNAPSHOT

Major Players

Study period:

2023-2028

Base Year:

2022

CAGR:

9

Fastest Growing Market:

APAC

Largest Market:

North America

REPORT DESCRIPTION

Live cell imaging associates with research of live cells through microscope. It helps in better understanding of characteristics and behaviour of cells. Researchers and scientists use live cell imaging for studying the biological functions. 

The global Live Cell Imaging (LCI) Market is expected to exceed US$ 11 Billion by 2028, with CAGR at 9% in the given forecast period. 
North America is leading market for live cell imaging industry by revenue which accounted largest share worldwide. Asia Pacific will grow with highest growth rate owing to increase in demand for live cell imaging in healthcare industry and oil and gas industryRising need of live cell imaging owing to increasing index of cancer victims is triggering the growth of the market.Its use in drug discovery is growth factor. High cost of imaging equipment is restraining factor for this market. It requires a skilled professional with immense knowledge for imaging and studying the live cells which is restraining factor.The global live cell imaging market by product equipment, consumables and software. According to its technology the market is further segmented in tofluorescence recovery after photobleaching (FRAP), fluorescence resonance energy transfer (FRET), high-content analysis (HCA), ratiometric imaging, fluorescence in situ hybridization (FISH), total internal reflection fluorescence microscopy (TRIF), multiphoton excitation microscopy (MPE) and other technologies. The application segment of live cell imaging market consists of cell biology, stem cells, developmental biology and drug discovery. The market segments in terms of geographical regions include North America, Europe, Asia-Pacific and Rest of the World(ROW).

This report provides: 

1) An overview of the global market for live cell imaging and related technologies.

2) Analyses of global market trends, with data from 2021, estimates for 2022 and 2023, and projections of compound annual growth rates (CAGRs) through 2027.

3) Identifications of new market opportunities and targeted promotional plans for live cell imaging market.

4) Discussion of research and development, and the demand for new products and new applications.

5) Comprehensive company profiles of major players in the industry. 

REPORT SCOPE: 

The scope of the report includes a detailed study of global and regional markets for various types of coatings with the reasons given for variations in the growth of the industry in certain regions.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include:

• Carl Zeiss AG

• Leica Microsystems

• Nikon Corporation

• Molecular Devices LCC

• PerkinElmer Inc.

• GE Healthcare

• Becton

• Dickinson and Company

• Olympus Corporation

• Sigma Aldrich Corporation

• Thermo Fisher Scientific Inc.

Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments. 

The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players. 

The Live cell imaging Market has been segmented as below: 

by Product

• Equipment

o Microscopes

? Conventional Microscopes

? Confocal Microscopes

? Advanced Fluorescence Microscopes

o Standalone Systems

o Cell Analyzers

o Image-capturing Devices

• Consumables

o Assay Kits

o Reagents

o Media

o Others

• Software

by Technology

• Fluorescence Recovery After Photobleaching (FRAP)

• Fluorescence Resonance Energy Transfer (FRET)

• High-content Analysis (HCA)

• Ratiometric Imaging

• Fluorescence In Situ Hybridization (FISH)

• Total Internal Reflection Fluorescence Microscopy (TRIF)

• Multiphoton Excitation Microscopy (MPE)

• Other Technologies

by Application

• Cell Biology

• Stem Cells

• Developmental Biology

• Drug Discovery

by Region

• North America

• Europe

• Asia Pacific

• Rest of the World (RoW)

Reasons to buy this Report: 

1) Obtains the most up to date information available on all active and planned live cell imaging industry globally.

2) Identify growth segments and opportunities in the industry.

3) Facilitate decision making on the basis of strong historic and forecast of live cell imaging industry and unit capacity data.

4) Assess your competitor’s refining portfolio and its evolution. 

Customization: 

We can offer you custom research reports as per client’s special requirements.

Below are our new reports:

breakthrough therapies market

Breast Biopsy Devices Market

breast cancer therapeutics market

Breast Lesion Guidance Systems Market

Breast Lesion Guidance Systems Market

1 INTRODUCTION    

    1.1    Key Take Aways    
    1.2    Report Description    
    1.3    Markets Covered    
    1.4    Stakeholders    
    1.5    Research Methodology    
        1.5.1    Market Size    
        1.5.2    Market Share    
        1.5.3    Key Data Points From Secondary Sources    
        1.5.4    Key Data Points From Primary Sources
 

2 Research Methodology
    2.1 Secondary and Primary Research Methodology
           2.1.1 Secondary Research
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Research
           2.1.3 Key Industry Insights
                    2.1.3.1 Key Data From Primary Sources
                    2.1.3.2 Key Insights From Primary Sources
    2.2 Market Size Estimation Methodology
    2.3 Market Forecast Methodology
    2.4 Market Data Validation and Data Triangulation
    2.5 Assumptions

 

3 Executive Summary
    3.1 Introduction
    3.2 Market Dynamics
           3.2.1 Live Cell Imaging Market, By Product
           3.2.2 Live Cell Imaging Instruments Market, By Type
           3.2.3 Live Cell Imaging Microscopy Market, By Type
           3.2.4 Live Cell Imaging Consumables Market, By Type
           3.2.5 Live Cell Imaging Market, By Technology
           3.2.6 Live Cell Imaging Market, By Application
           3.2.7 Live Cell Imaging Market, By Region
    3.3 Market Share
    3.4 Competitive Landscape
    3.5 Key Players

 

4 Premium Insights
    4.1 Global Live Cell Imaging Market Size
    4.2 Global Live Cell Imaging Market, By Product
    4.3 Live Cell Imaging Market, By Application and Region
    4.4 Live Cell Imaging Microscopes Market, By Type
    4.5 Regional Snapshot

 

5 Market Overview
    5.1 Introduction
    5.2 Market Segmentation
    5.3 Market Dynamics
           5.3.1 Drivers
                    5.3.1.1 Adoption of High-Content Screening Techniques in Drug Discovery
                    5.3.1.2 Rising Incidence of Cancer
                    5.3.1.3 Government Funding for Cell-Based Research
           5.3.2 Restraints
                    5.3.2.1 High Cost of High-Content Screening Systems
                    5.3.2.2 Shortage of Skilled Professionals
           5.3.3 Challenge
                    5.3.3.1 Maintaining Cell Viability & Cellular Environment in the Culture
           5.3.4 Opportunities
                    5.3.4.1 Asian Market Presents High-Growth Opportunities
                    5.3.4.2 Adoption of HCS for Primary Screening
                    5.3.4.3 Application of Live Cell Imaging Techniques in Personalized Medicine

 

6 Industry Trends
    6.1 End-User Market Potential Analysis
           6.1.1 Academic and Government Institutes
           6.1.2 Pharmaceutical and Biotechnology Companies
           6.1.3 Contract Research Organizations (CRO)
           6.1.4 Diagnostic Laboratories
    6.2 Supply Chain Analysis
           6.2.1 Prominent Companies
           6.2.2 Small and Medium Enterprises
           6.2.3 End Users
           6.2.4 Key Influencers

 

7 Market Potential Analysis
    7.1 Introduction
    7.2 Unmet Needs/Limiting Factors
    7.3 Winning Imperatives to Boost the Adoption of Live Cell Imaging Techniques

 

8 Live Cell Imaging Market, By Product
    8.1 Introduction
    8.2 Instruments
           8.2.1 Standalone Systems
           8.2.2 Microscopes
                    8.2.2.1 Conventional Microscopes
                    8.2.2.2 Confocal Microscopes
                    8.2.2.3 Advanced Fluorescence Microscopes
           8.2.3 Cell Analyzers
           8.2.4 Image Capturing Devices
    8.3 Consumables
           8.3.1 Assay Kits
           8.3.2 Reagents
           8.3.3 Media
           8.3.4 Other Consumables
    8.4 Software

 

9 Live Cell Imaging Market, By Technology
    9.1 Introduction
    9.2 Fluorescence Resonance Energy Transfer (FRET)
    9.3 Fluorescence in Situ Hybridization (FISH)
    9.4 High-Content Screening (HCS)
    9.5 Fluorescence Recovery After Photobleaching (FRAP)
    9.6 Ratiometric Imaging
    9.7 Total Internal Reflection Fluorescence Microscopy (TRIF)
    9.8 Multiphoton Excitation Microscopy (MPE)
    9.9 Other Technologies

 

10 Live Cell Imaging Market, By Application
     10.1 Introduction
     10.2 Cell Biology
     10.3 Stem Cells
     10.4 Developmental Biology
     10.5 Drug Discovery

 

11 Live Cell Imaging Market, By Region
     11.1 Introduction
     11.2 North America
             11.2.1 U.S.
                        11.2.1.1 Increasing Incidence of Cancer to Propel the Live Cell Imaging Market in the U.S.
                        11.2.1.2 Growth in Pharmaceutical & Biotechnology Industries in the U.S. to Drive the Market
                        11.2.1.3 High-Content Screening (HCS) Conferences in the U.S.
             11.2.2 Canada
                        11.2.2.1 Increasing Investments By the Canadian Government on Regenerative Medicine to Spur Market Growth
                        11.2.2.2 Drug Discovery Research in Canada to Boost Market Growth
     11.3 Europe
                        11.3.1.1 Increasing Government Funding in Europe to Drive the Market
             11.3.2 U.K.
                        11.3.2.1 Conferences on Live Cell Imaging to Propel Market Growth
             11.3.3 Germany
                        11.3.3.1 Advancements in Biotechnology Likely to Fuel the Live Cell Imaging Market in Germany
             11.3.4 France
                        11.3.4.1 Advancements in the Biotechnology Sector in France
             11.3.5 Rest of Europe (RoE)
                        11.3.5.1 Increasing Research on Regenerative Medicine in Spain to Drive the Market
     11.4 Asia
             11.4.1 India
                        11.4.1.1 Growing Pharmaceutical Industry to Spur the Market in India
             11.4.2 China
                        11.4.2.1 Rising Burden of Cancer in China
                        11.4.2.2 Developing Pharmaceutical Industry in China
                        11.4.2.3 Increasing Government Investment in the Life Sciences Sector in China
                        11.4.2.4 Conferences on Live Cell Imaging in China
             11.4.3 Japan
                        11.4.3.1 Growing Focus on Stem Cell Research in Japan
                        11.4.3.2 Regenerative Medicine, and Biomedical and Medical Research Set to Trigger Growth of the Live Cell Imaging Market
             11.4.4 Rest of Asia (RoA)
                        11.4.4.1 Increasing Government Support for Strong Academic and Commercial R&D Activities in Taiwan
             11.4.5 Rest of the World (RoW)
                        11.4.5.1 Flourishing Biotechnology and Pharmaceutical Markets in Brazil
                        11.4.5.2 Significant Developments in the Pharmaceutical Market in Africa

 

12 Competitive Landscape
     12.1 Market Share Analysis
             12.1.1 Introduction
             12.1.2 Carl Zeiss AG
             12.1.3 Nikon Corporation
             12.1.4 Leica Microsystems (Acquired By Danaher Corporation)
     12.2 Competitive Situation and Trends
             12.2.1 Introduction
             12.2.2 New Product Launches
             12.2.3 Agreements/Partnerships/Collaborations
             12.2.4 Expansions
             12.2.5 Acquisitions
             12.2.6 Others

The Live cell imaging Market has been segmented as below: 

by Product

• Equipment

o Microscopes

? Conventional Microscopes

? Confocal Microscopes

? Advanced Fluorescence Microscopes

o Standalone Systems

o Cell Analyzers

o Image-capturing Devices

• Consumables

o Assay Kits

o Reagents

o Media

o Others

• Software

by Technology

• Fluorescence Recovery After Photobleaching (FRAP)

• Fluorescence Resonance Energy Transfer (FRET)

• High-content Analysis (HCA)

• Ratiometric Imaging

• Fluorescence In Situ Hybridization (FISH)

• Total Internal Reflection Fluorescence Microscopy (TRIF)

• Multiphoton Excitation Microscopy (MPE)

• Other Technologies

by Application

• Cell Biology

• Stem Cells

• Developmental Biology

• Drug Discovery

by Region

• North America

• Europe

• Asia Pacific

• Rest of the World (RoW)

Got a question? We've got answers. If you have some other questions, see our support center.

The market is expected to grow at a CAGR of 9% during the study period (2023-2028)
Global live cell imaging market was accounted US$ 11 billion in 2028
The segment included in live cell imaging market is Product, Technology, Application and region.
Some key players operating in the live cell imaging market include Carl Zeiss AG, Leica Microsystems, Nikon Corporation, Molecular Devices LCC, PerkinElmer Inc., GE Healthcare , Becton, Dickinson and Company.
We can offer several formats of the market research reports including, • PDF • PPT • Spreadsheet/ Workbook

Related Reports